Bureaucratic Backlog

Townhall.com Staff
Posted: Mar 20, 2014 11:18 AM
In 2010 a Swiss company successfully completed Phase III trials for a groundbreaking vaccine to fight a rare but deadly strain of meningitis. Four years later, outbreaks of Meningitis type B (MenB) are spreading in college campuses across the United States, though the product still awaits approval by the Food and Drug Administration.